Back to results
US 2008/0305108 A1Published application
Peptides of Il1 Beta and Tnf Alpha and Method Treatment
AssigneeVaxconsulting
InventorJean-Francois Zagury
Life of this patent
Estimating the term…
Abstract
The present invention relates to peptides derived from the proinflammatory cytokines, interleukin-1β, (IL1β) and tumor necrosis factor α, (TNFα), and their use in human or veterinary therapy, such as to generally treat diseases linked to the overproduction of IL1β or TNFα as well as acute or chronic inflammatory diseases, rheumatoid arthritis, septic shock, autoimmune diabetes, graft rejection in the host, etc.
Claims20
A peptide originating from mammalian IL1β or TNFα cytokines, homologous to one of the following peptides of human IL1β or TNFα cytokines:
- 80 ISRIAVSYQTKVNLLS 95 (SEQ ID NO:2)
- 140 DYLDFAESGQVY 150 (SEQ ID NO:5)
- 3 VKSLNCTLRDSQQKSL 18 (SEQ ID NO:7)
- 45 SFVQGEESNDKIP 57 (SEQ ID NO:8)
- 89 NYPKKKMEKRFVFNKIEI 106 (SEQ ID NO:9)
- 121 YISTSQAENMPVFLG 135 (SEQ ID NO:4)
- 143 ITDFTMQFVSS 153 (SEQ ID NO:10)
4 more elements
(canceled)
(canceled)
Dependencies are inferred from the claim text.